We received an important pricing notification from UCB regarding the contract price for Cimzia® (cerolizumab).
Please be advised that effective April 1, 2018, UCB will make Cimzia available for purchase by GPO participants at the price listed in the below table
Please be advised that effective April 1, 2018, UCB will make Cimzia available for purchase by GPO participants at the price listed in the below table
*This price is based on the CMS’s current payment limit per milligram for HCPCS Code J0717 multiplied by 0.90. The payment limit for Cimzia (certolizumab pegol), HCPCS code J0717, is updated by CMS on a quarterly basis, and published at http://www.cms.gov/McrPartBDrugAvgSalesPrice/.
If you have any questions, please contact your UCB representative.
Please visit www.ucb.com for full prescribing information.
If you have any questions, please contact your UCB representative.
Please visit www.ucb.com for full prescribing information.